TY  - JOUR
AU  - Busca, Alessandro
AU  - Salmanton-García, Jon
AU  - Corradini, Paolo
AU  - Marchesi, Francesco
AU  - Cabirta, Alba
AU  - Di Blasi, Roberta
AU  - Dulery, Remy
AU  - Lamure, Sylvain
AU  - Farina, Francesca
AU  - Weinbergerová, Barbora
AU  - Batinić, Josip
AU  - Nordlander, Anna
AU  - López-García, Alberto
AU  - Drgoňa, Ľuboš
AU  - Espigado-Tocino, Ildefonso
AU  - Falces-Romero, Iker
AU  - García-Sanz, Ramón
AU  - García-Vidal, Carolina
AU  - Guidetti, Anna
AU  - Khanna, Nina
AU  - Kulasekararaj, Austin
AU  - Maertens, Johan
AU  - Hoenigl, Martin
AU  - Klimko, Nikolai
AU  - Koehler, Philipp
AU  - Pagliuca, Antonio
AU  - Passamonti, Francesco
AU  - Cornely, Oliver A
AU  - Pagano, Livio
PY  - 2022
DO  - 10.1182/bloodadvances.2021005616
UR  - http://hdl.handle.net/10668/20249
T2  - Blood advances
AB  - The EHA-IDWP developed an observational registry collecting data on COVID-19 infection in patients who received CAR T-cell therapy. Prevalence of COVID-19 was 4.8%, and overall mortality was 50%, highlighting the need for prevention of infection in...
LA  - en
KW  - COVID-19
KW  - Humans
KW  - Immunotherapy, Adoptive
KW  - Receptors, Chimeric Antigen
KW  - T-Lymphocytes
TI  - COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP.
TY  - research article
VL  - 6
ER  -